. german chancellor angela merkel (bottom left) was straightforward when she said enlargment was not on the table at the sofia summit .
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.: "fremanezumab for the preventive treatment of chronic migraine."
.